Silver Book Fact

Goel S, Bajaj N, Agaarwall B, et al. Prevalence and Outcomes of Unoperated Patients with Severe Symptomatic Mitral Regurgitation and Heart Failure. J Am Coll Cardiol. 2014; 63(2). http://www.onlinejacc.org/content/63/2/185

Reference

Title
Prevalence and Outcomes of Unoperated Patients with Severe Symptomatic Mitral Regurgitation and Heart Failure
Publication
J Am Coll Cardiol
Publication Date
2014
Authors
Goel S, Bajaj N, Agaarwall B, et al
Volume & Issue
Volume 63, Issue 2
URL
Read Full Resource

Categories

  • Cost of Disease

Related Facts

  • Moderate or severe aortic valve disease is present in 4.2% to 10.7% of the population ages 65 and older.
     
  • Lifespan of Medicare patients with sSAS who do not undergo treatment
    Medicare patients with severe symptomatic aortic stenosis (sSAS) who do not undergo treatment have an average lifespan of 1.8 years.  
  • Survival rates for patients with sSAS without repair or replacement
     
  • Projections of Significant Heart Valve Disease — Diagnosed & Undiagnosed — in the 65+ U.K. Population
     
  • Aortic stenosis impacts majority of heart valve disease patients
    Aortic stenosis (AS) is among the most common forms of heart valve disease (HVD), affecting 2% to 3% of the adult U.S. population.